Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease

US Patent 11304932 · Granted Apr 19, 2022

Assignee

Inventors

View full patent text on Google Patents →